Cargando…

Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague

Plague pandemics and outbreaks have killed millions of people during the history of humankind. The disease, caused by the bacteria Yersinia pestis, is currently treated effectively with antibiotics. However, in the case of multidrug-resistant (MDR) bacteria, alternative treatments are required. Bact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vagima, Yaron, Gur, David, Aftalion, Moshe, Moses, Sarit, Levy, Yinon, Makovitzki, Arik, Holtzman, Tzvi, Oren, Ziv, Segula, Yaniv, Fatelevich, Ella, Tidhar, Avital, Zauberman, Ayelet, Rotem, Shahar, Mamroud, Emanuelle, Steinberger-Levy, Ida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024586/ https://www.ncbi.nlm.nih.gov/pubmed/35458417 http://dx.doi.org/10.3390/v14040688

Ejemplares similares

Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
por: Aftalion, Moshe, et al.
Publicado: (2023)

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017)

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2015)

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
por: Levy, Yinon, et al.
Publicado: (2018)

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model
por: Gur, David, et al.
Publicado: (2018)

Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages
por: Moses, Sarit, et al.
Publicado: (2021)

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system
por: Tidhar, Avital, et al.
Publicado: (2019)

Early sensing of Yersinia pestis airway infection by bone marrow cells
por: Vagima, Yaron, et al.
Publicado: (2012)

Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection
por: Israeli, Ofir, et al.
Publicado: (2021)

YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Correction: YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2014)

Correction: Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response
por: Moses, Sarit, et al.
Publicado: (2021)

The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague
por: Tidhar, Avital, et al.
Publicado: (2009)

Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague
por: Zauberman, Ayelet, et al.
Publicado: (2009)

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
por: Vagima, Yaron, et al.
Publicado: (2020)

A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers
por: Shifman, Ohad, et al.
Publicado: (2019)

Screening of an FDA-Approved Library for Novel Drugs against Y. pestis
por: Gur, David, et al.
Publicado: (2021)

Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures
por: Shifman, Ohad, et al.
Publicado: (2021)

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
por: Kon, Edo, et al.
Publicado: (2023)

Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection
por: Mechaly, Adva, et al.
Publicado: (2021)

Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection
por: Sittner, Assa, et al.
Publicado: (2018)

Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay
por: Bar-Haim, Erez, et al.
Publicado: (2019)

Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases
por: Aftalion, Moshe, et al.
Publicado: (2021)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
por: Gutman, Hila, et al.
Publicado: (2022)

An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis
por: Makdasi, Efi, et al.
Publicado: (2022)

Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy
por: Melamed, Sharon, et al.
Publicado: (2021)

PEG-fibrinogen hydrogel microspheres as a scaffold for therapeutic delivery of immune cells
por: Cohen, Noam, et al.
Publicado: (2022)

Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies
por: Noy-Porat, Tal, et al.
Publicado: (2021)

MAPt: A Rapid Antibiotic Susceptibility Testing for Bacteria in Environmental Samples as a Means for Bioterror Preparedness
por: Aloni-Grinstein, Ronit, et al.
Publicado: (2020)

Rapid Antibiotic Susceptibility Determination for Yersinia pestis Using Flow Cytometry Spectral Intensity Ratio (SIR) Fluorescence Analysis
por: Zahavy, Eran, et al.
Publicado: (2018)

Rapid Antibiotic Susceptibility Testing of Tier-1 Agents Bacillus anthracis, Yersinia pestis, and Francisella tularensis Directly From Whole Blood Samples
por: Rotem, Shahar, et al.
Publicado: (2021)

Plague Tractates
por: Singer, Dorothea Waley, et al.
Publicado: (1917)

Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
por: Rotem, Shahar, et al.
Publicado: (2021)

Distinct Contribution of the HtrA Protease and PDZ Domains to Its Function in Stress Resilience and Virulence of Bacillus anthracis
por: Israeli, Ma’ayan, et al.
Publicado: (2019)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes
por: Steinberger-Levy, Ida, et al.
Publicado: (2016)

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
por: Noy-Porat, Tal, et al.
Publicado: (2021)

SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine
por: Rosen, Osnat, et al.
Publicado: (2022)

In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique
por: Makovitzki, Arik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_79m57k7ea1eg8qn0536aq51ahh